Dr. Maha Mohamed Tawfik Elzimaity | Get Medical Second Opinion Online
Dr. Maha Mohamed Tawfik Elzimaity
0 / 1 vote

Dr. Maha Mohamed Tawfik Elzimaity Verified by iCliniq

Professional Bio:  Dr. Maha Mohamed Tawfik Elzimaity is a Hematologist with 41 years of clinical experience. She is working as a Professor at Ain Shams University. She completed her MBBCh, MD (Internal medicine), and Ph... Read More 




41+ Yrs


Helped 2000 patients


Query : $49

Phone/Video : $59

Professional Bio

Dr. Maha Mohamed Tawfik Elzimaity is a Hematologist with 41 years of clinical experience. She is working as a Professor at Ain Shams University. She completed her MBBCh, MD (Internal medicine), and Ph.D. (Internal Medicine) following Fellowship Clinical Hematology and Bone Marrow Transplantation. She worked as a clinical hematology and bone marrow consultation consultant in Saudi Arabia at Riyadh Military hospital from 2008 to 2011.

Academics & Trainings


Ain Shams University



Ain Shams University



Ain Shams University


Awards & Publications

Dr. Maha Mohamed Tawfik Elzimaity has done the following publications: 1) El Zimaity M, Bayle C, Sabbour MSImmunologic and morphologic typing as a prognostic factor in M1 acute myeloblastic leukemia. J Chemother. 1990 Apr;2(2):136-42. 2) Talkan HA, SalehWA, Lotfi OA, Lotfi AA, El Zimaity M: Serum level IL10, TNF, and neopterin in chronic hepatitis C virus infection and their relation to viral load. Ain Shams Med J 1998; 49:939-948. 3) Abd el Alim M, Tharwat A, El Zimaity M: Clinical and bacteriological aspects of Acinetobacter septicemia. Sc Med J ESCME 1998; 9:13-24. 4) Fathy OFM, Asfour I, el Kholy N, El Zimaity M: Serum Erythropoietin in adult lymphoma patients. J of Egyptian Sc of Hematol 1998;23,4:507-516. 5) Abou Ali F., El Zimaity M., el-Fiky R., el-Zimaity D.: Relation between chronic helicobacter pylori infection and acute ischemic cerebrovascular stroke. Sc J. of Al-Azhar Faculty 1999;20,1:783-797. 6) El Zimaity M., Abdel-Khalik H., Hassan F., Kholif T., Abdel-Fatah H: Study of blood levels of zinc in diabetic and non-diabetic patients with chronic renal failure under conservative and hemodialysis therapy. Egyptian J. of Applied Endocrinology 1999;17,1:1-14. 7) El-Mahrakawy S., El Zimaity M., AbouAli F., Moustafa N., el-Zimaity D., Moustafa A.: Experience in managing 156 patients with hepatocellular carcinoma. Sc. J. of MounifyiaUniv. 1999;11,2:1-11. 8) El Zimaity M., Soliman Abdel R., Zaglol A., Hamed H., Abdel-Wahid E., el-Zimaity D.: Clinical value of serum CA125 in some hematological malignancies.Egyptian J. of Haematology 2000;25,3:395-414. 8) Mabrouk R, Zakaria N, Mahran M, Talkan H, El Zimaity M: TH1 & TH2 imbalance and autoantibodies in healthy first-degree relatives of patients with type-1 diabetes mellitus. Egyptian J. of Applied Endocrinology2000;18,1:45-58. 9) Monis A., El Zimaity M, El Tony M, Hamed H, Guinaidy M, Mabrouk S: A study of angiogenesis in chronic hepatitis and its possible role in hepatocellular carcinoma. The Egyptian J. of Gastroenterology 2000;5,2:211-220. 10) Osman A, Omar I, Shams M, El-Sewefy D, El Zimaity M. Evaluation of serum vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF) and bone marrow vascularity in acute leukemia: their relation to disease outcome. The Egyptian Journal of Haematology 2003;28(3):500-516. 11) El Zimaity M, Kantarjian H, Talpaz M, O’Brien S, Giles F, Garcia-Manero G, Verstovsek S, Thomas D, Ferrajoli A,. Hayes K, Bekele N, Zhou X, Rios MB, Glassman A, Cortes J: Imatinib mesylate therapy in chronic myelogenous leukemia with variant Philadelphia chromosome (Ph).BMJ 2004; 125: 187-195. 12) El Zimaity M, Saliba R, Chan K, Shahjahan M, Carrasco A, Khorshid O, Caldera H, Couriel D, Giralt S, Khouri I, Ippopliti C, Champlin R, de Lima M. Hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation: donor type matter. Blood 2004;103(12): 4674-80. 13) Moustafa A, El Zimaity M, Hamed H, Abd El Wahed E, Medhat N, El-Zimaity D: Clinical implications of cytomegalovirus and human parvovirus B19 infections in adult patients with hematological malignancies on chemotherapy. The Egyptian Journal of Hematology 2004;29(2):249-261. 14) El Zimaity M, Shehab A, Shams EldinEltelbany M, Abd El-AleemMostafa A: Mutant P53 expression as a prognostic marker in acute and chronic leukemia. Ain Shams Medical Journal 2004;55(4,5&6):433-447. 15) Hamed H, El Zimaity M, Shehab A, El-Zimaity D: Differential expression of HLA DR, CD80, CD86 in lymphoproliferative malignancies and their impact on patients’ prognosis and survival. Egyptian Society of Hematology 2004;29(3):391-405. 16) Fahim N, El Zimaity M, Hamed H, Shoukeir M: Expression of CD95 receptor and CD95 ligand in acute leukemia. Egyptian Journal of Hematology 2005;30(1): 77-90. 17) Shafik M, AbedelRahim A, Badawy M, El Zimaity M, AbdelWaheed E, Korah E: Role of polymorph nuclearelastase and interleukin-8 in complicated and non-complicated pleural effusions.The Egyptian Journal of Chest diseases and tuberculosis 2004; 53(1):15-22. 18) Fathy O, El Zimaity M, AbdelWaheed E, Hamed H, Youssef A Soluble Fas antigen as a marker of apoptosis in patients with chronic hepatitis C and hepatocellular carcinoma: relationship to disease activity. The Egyptian Journal of gastroenterology2004;9(1): 203-212. 19) El Zimaity Maha, AyoubMaryse, Adel Nannies, HabibBassem, SalakawyWalaa. Cardiopulmonary assessment in patients with beta-thalassemia The Egyptian Journal of hematology 2007;32(number 3&4):129-138. 20) El Zimaity M, Hassan E, , Abd El-Wahab S, Abd El-Ghaffar A,. Mahmoud N, Elafifi A, Moussa M, El-Gohary G, Hagras M, Mowafy N Stem cell transplantation in hematological disorders A developing country experience-impact of cost considerations Saudi Med J 2008; Vol. 29 (10): 1484-1489. 21) Leandro de Padua Silva, Poliana A. Patah, Rima M. Saliba, Nicholas A. Szewczyk, Lisa Gilman, Joyce Neumann, Xiang-Yang Han, Jeffrey Tarrant, Rachel Ribeiro, Alison Gulbis, Elizabeth J. Shpall, Roy Jones, UdayPopat, Julia A. Walker, Demetrios Petropoulos, AlexandreChiattone, John Stewart, El Zimaity M, Paolo Anderlini, Sergio Giralt, Richard E Champlin, and Marcos de Lima Hemorrhagic cystitis after allogeneic hematopoietic stem cell transplants are the complex result of BK virus infection, preparative regimen intensity, and donor type Haematologica. 2010;95(7):1183-90. 22) Elyamany G, Khan M, El-Hag I, El-Zimaity M, Albalawi M, and Abdulaziz AL Abdulaaly A Generalized Lymphadenopathy as the First Presentation of Granulocytic Sarcoma: A Diagnostic Challenge Case Reports in Medicine 2013;2013: 5. 23) El-Ghammaz A. & Ben Matoug R & Elzimaity M & Mostafa N: Nutritional status of allogeneic hematopoietic stem cell transplantation recipients: influencing risk factors and impact on survival. Support Care Cancer 2017;25:3085–3093. Abstracts: 1) Fathy O, Soliman A, Fayek M, El Zimaity M, Abdel Wahid E, Soliman M. The role of thrombopoietin in thrombocytopenia due to various etiologies. XVI the meeting of the international society of hematology 2002, abstract no: PE 10/4. 2) Anagnostopoulos A, El Zimaity M, Munsell M, Wong R, Giralt S, Champlin R, DeLima M: Unrelated donor bone marrow transplant (UDT) for adults with AML/MDS: improved quality of life (QOL) with reduced-intensity preparative regimens (RIPR). ASH 2002; abstract number 3379. 3) El Zimaity HMT, Katsuyama T, Peterson L, Luca J, Ota H, Reggae M, El Zimaity M, Graham DY: High frequency of Chromosome X gains is characteristic of gastric MALT lymphoma: comparative genomic hybridization using gene-cluster analysis. Gastroenterology 2004: 126 4) Fellow clinical hematology and bone marrow transplantation at Gustave Rousssy Institute for one year from 1987-1988. And Fellowship clinical hematology and bone marrow transplantation at MDAnderson Cancer Institute from 2001-2003.

In-Person Consultation

Ain Shams University clinical hematology and bone marrow transplantation unit

Abassia Square, Cairo, Cairo Governorate, Zip: 11566, EG